🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
90 Servings
Other Combinations Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

150 mcg (100% DV)
✅ Within RDA (1.0× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.15mg UL 1.1mg
Sea Kelp
50 mg
raw Bovine Thyroid Concentrate
40 mg
raw Spleen Concentrate
40 mg
raw Thymus concentrate
40 mg

Other Ingredients

Rice Flour Gelatin Vegetable Lubricant

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (74% of products) Nutrient (53% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Sugar Free

Product Information

📋 Directions for Use

Directions: One capsule daily, or more, as directed by a health care professional.

⚠️ Warnings & Precautions

Sold only for dispensing by a licensed health professional.

Not to be used by pregnant or lactating women.

Tamper evident band around cap and seal on bottle. Do not use if either seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

The glandular concentrate in this product is prepared by a special process which does not exceed physiological temperature (37 degrees C).

Guaranteed free of chemical pesticides and synthetic hormones. Contains no sugar, yeast, corn, soy, wheat, artificial colors or preservatives.

Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)

Iodine with thyroxin free thyroid, thymus & spleen concentrates

Iodine with thyroxin free thyroid, thymus & spleen concentrates

Additional Information

GMP Good Manufacturing Practice Certified GMP Compliant 21 CFR 111

Product Details

UPC / SKU 3 51821 00421 1
DSLD Entry Date 2022-04-11
Product Type Other Combinations
Form Capsule
DSLD ID 263246
Data Updated 2026-04-11

Research Evidence

292 Research Sources
57 Avg Quality Score
160 Meta Analysis
70 Systematic Review
36 Rct
8 Cochrane Review
8 Clinical Trial
3 Regulatory Source
2 Narrative Review
2 Other
1 Guideline
1 Openfda Safety
A Umbilical cord antiseptics for preventing sepsis and death among newborns
Meta Analysis The Cochrane database of systematic reviews 2026
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Interventions for cutaneous molluscum contagiosum
Meta Analysis The Cochrane database of systematic reviews 2017
A Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections: A Systematic Review and Meta-Analysis
Meta Analysis JAMA network open 2026
B Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Meta Analysis JAMA otolaryngology-- head & neck surgery 2021
B Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Meta Analysis European journal of nuclear medicine and molecular imaging 2022
B Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials
Meta Analysis The Lancet. Infectious diseases 2022
B Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
B Interventions for ingrowing toenails
Meta Analysis The Cochrane database of systematic reviews 2012
B Interventions for the management of malignant pleural effusions: a network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2016
View all evidence for Iodine →

Compare Similar Products

View all Iodine products →